Resverlogix Corporation (RVX-TSX)
Interview with: Donald J. McCaffrey, Co-Founder, President and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their groundbreaking research in the areas of cardiovascular disease, cancer, and fibrotic diseases.

Cover Story

CEOCFO Current Issue

Cover Story Archives

Private Equity Review

CEOCFO Interview Index

Future Features

Analyst Interviews

Corporate Financials

Contact & Ordering

This is a printer friendly page!

Resverlogix is a cholesterol management company that has focused on increasing HDL (the good cholesterol) as opposed just lowering LDL the bad cholesterol



Healthcare
Biotechnology
(RVX-TSX)

Resverlogix Corporation




Donald J. McCaffrey
Co-Founder, Pres. And CEO

Interview conducted by:
Lynn Fosse, Senior Editor
CEOCFOinterviews.com
April 21, 2005

To order the complete April 21, 2005 Issue of CEOCFOinterviews.com left click below for our secure forms:

Purchase NOW!

There is a $5.00 charge for each current issue!
You will be emailed your Current Issue and an invoice for Credit Card payment!

disclaimers

Any reproduction or further distribution of this article without the express written consent of CEOCFOinterviews.com is prohibited.

"The hard cold facts of it are that if we all ate better, exercised better, etc., a good portion of the problem would not exist, but unfortunately that is not the human way. Resverlogix is offering a small molecule that has low toxicity and few side-effects; we feel that is probably the direction that most people would prefer to go." - Donald J. McCaffrey

Newsflash!

To view Releases highlight & left click on the company name!